161 related articles for article (PubMed ID: 32910411)
1. Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation.
Park GY; Pathak HB; Godwin AK; Kwon Y
Cell Oncol (Dordr); 2021 Feb; 44(1):77-92. PubMed ID: 32910411
[TBL] [Abstract][Full Text] [Related]
2. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
Dong YL; Kabir SM; Lee ES; Son DS
PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
[TBL] [Abstract][Full Text] [Related]
4. An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.
Young HL; Rowling EJ; Bugatti M; Giurisato E; Luheshi N; Arozarena I; Acosta JC; Kamarashev J; Frederick DT; Cooper ZA; Reuben A; Gil J; Flaherty KT; Wargo JA; Vermi W; Smith MP; Wellbrock C; Hurlstone A
J Exp Med; 2017 Jun; 214(6):1691-1710. PubMed ID: 28450382
[TBL] [Abstract][Full Text] [Related]
5. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote proliferation of endometrial cancer cells.
Subramaniam KS; Tham ST; Mohamed Z; Woo YL; Mat Adenan NA; Chung I
PLoS One; 2013; 8(7):e68923. PubMed ID: 23922669
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CXCL1-CXCR2 axis ameliorates cisplatin-induced acute kidney injury by mediating inflammatory response.
Liu P; Li X; Lv W; Xu Z
Biomed Pharmacother; 2020 Feb; 122():109693. PubMed ID: 31812015
[TBL] [Abstract][Full Text] [Related]
8. Participation of CXCL1 in the glial cells during neuropathic pain.
Moraes TR; Elisei LS; Malta IH; Galdino G
Eur J Pharmacol; 2020 May; 875():173039. PubMed ID: 32119843
[TBL] [Abstract][Full Text] [Related]
9. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor.
Bolitho C; Hahn MA; Baxter RC; Marsh DJ
Endocr Relat Cancer; 2010 Dec; 17(4):929-40. PubMed ID: 20702723
[TBL] [Abstract][Full Text] [Related]
10. Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKCδ and PKCε activators.
Erin N; Tavşan E; Akdeniz Ö; Isca VMS; Rijo P
Cytokine; 2021 Jun; 142():155498. PubMed ID: 33773907
[TBL] [Abstract][Full Text] [Related]
11. Effects of macrophages and CXCR2 on adipogenic differentiation of bone marrow mesenchymal stem cells.
Cao D; Ma F; Ouyang S; Liu Z; Li Y; Wu J
J Cell Physiol; 2019 Jun; 234(6):9475-9485. PubMed ID: 30362570
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis.
Kinoshita H; Hirata Y; Nakagawa H; Sakamoto K; Hayakawa Y; Takahashi R; Nakata W; Sakitani K; Serizawa T; Hikiba Y; Akanuma M; Shibata W; Maeda S; Koike K
PLoS One; 2013; 8(4):e60914. PubMed ID: 23593346
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer.
Lee CH; Syu SH; Liu KJ; Chu PY; Yang WC; Lin P; Shieh WY
Oncotarget; 2015 Nov; 6(36):38866-80. PubMed ID: 26462152
[TBL] [Abstract][Full Text] [Related]
14. The chemokine CXCL1 and its receptor CXCR2 contribute to chronic stress-induced depression in mice.
Chai HH; Fu XC; Ma L; Sun HT; Chen GZ; Song MY; Chen WX; Chen YS; Tan MX; Guo YW; Li SP
FASEB J; 2019 Aug; 33(8):8853-8864. PubMed ID: 31034777
[TBL] [Abstract][Full Text] [Related]
15. CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms.
Bernard S; Myers M; Fang WB; Zinda B; Smart C; Lambert D; Zou A; Fan F; Cheng N
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):249-267. PubMed ID: 30094610
[TBL] [Abstract][Full Text] [Related]
16. CXCL1 regulation in human pulmonary epithelial cells by tumor necrosis factor.
Shieh JM; Tsai YJ; Tsou CJ; Wu WB
Cell Physiol Biochem; 2014; 34(4):1373-84. PubMed ID: 25301363
[TBL] [Abstract][Full Text] [Related]
17. Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.
Agarwal A; Tressel SL; Kaimal R; Balla M; Lam FH; Covic L; Kuliopulos A
Cancer Res; 2010 Jul; 70(14):5880-90. PubMed ID: 20570895
[TBL] [Abstract][Full Text] [Related]
18. Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation.
Yu B; Wong MM; Potter CM; Simpson RM; Karamariti E; Zhang Z; Zeng L; Warren D; Hu Y; Wang W; Xu Q
Stem Cells; 2016 Sep; 34(9):2368-80. PubMed ID: 27300479
[TBL] [Abstract][Full Text] [Related]
19. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression.
Ignacio RM; Kabir SM; Lee ES; Adunyah SE; Son DS
PLoS One; 2016; 11(10):e0164189. PubMed ID: 27723802
[TBL] [Abstract][Full Text] [Related]
20. Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling.
Pasonen-Seppänen S; Takabe P; Edward M; Rauhala L; Rilla K; Tammi M; Tammi R
Histochem Cell Biol; 2012 Dec; 138(6):895-911. PubMed ID: 22825838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
